Develops drugs for infectious diseases.
Jun 2026Revenue $1.11M/yrExpenses $9.72M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will 60 Degrees Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $1.11M and expenses $9.72M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $1.01M | $8.76M | −$7.76M |
| Dec 2024 | $608K | $10.3M | −$9.72M |
| Dec 2023 | $254K | $5.41M | −$5.15M |
| Dec 2022 | $223K | $1.97M | −$1.75M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.